Human Immunoglobulin G class drugs

15 results

  • bivigam

    (Immune Globulin Intravenous (Human) 10%)
    ADMA Biologics, Inc.
    BIVIGAM is indicated for treating primary humoral immunodeficiency (PI) in adults and children aged 2 years and older. It addresses conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

  • cuvitru

    (Immune Globulin Subcutaneous (Human))
    Takeda Pharmaceuticals America, Inc.
    CUVITRU is indicated for replacement therapy in primary humoral immunodeficiency (PI) in patients aged two years and older. Conditions treated include common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

  • flebogamma

    (Immune Globulin (Human))
    GRIFOLS USA, LLC
    Flebogamma 5% DIF is an intravenous immune globulin indicated for adults and children aged 2 and older to treat primary immunodeficiency, including conditions like common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syndrome.

  • gamastan

    (immune globulin (human))
    GRIFOLS USA, LLC
    GAMASTAN is a human immune globulin indicated for prophylaxis against hepatitis A after exposure, preventing measles in susceptible individuals, modifying varicella, and reducing rubella risk in exposed women who won't consider abortion. It is not intended for hepatitis B prophylaxis or routine prevention of certain other infections.

  • gammagard liquid

    (Immune Globulin Infusion (Human))
    Takeda Pharmaceuticals America, Inc.
    GAMMAGARD LIQUID is indicated for replacement therapy in primary immunodeficiency (PI) in patients aged two or older, and as maintenance therapy to improve muscle strength in adult patients with multifocal motor neuropathy (MMN) and to reduce disability in chronic inflammatory demyelinating polyneuropathy (CIDP).

  • gammaked

    (Immune Globulin (Human))
    KEDRION BIOPHARMA, INC.
    GAMMAKED is indicated for the treatment of primary humoral immunodeficiency in patients aged 2 and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to improve disability and prevent relapse.

  • gammaplex

    (HUMAN IMMUNOGLOBULIN G)
    Bio Products Laboratory Limited
    GAMMAPLEX 5% is indicated for replacement therapy in primary humoral immunodeficiency in patients aged 2 years and older, and for the treatment of chronic immune thrombocytopenic purpura (ITP) to raise platelet counts.

  • gamunex-c

    (Immune Globulin (Human))
    GRIFOLS USA, LLC
    GAMUNEX-C is indicated for treating primary humoral immunodeficiency in patients aged 2 and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to enhance neuromuscular function and prevent relapses.

  • hizentra

    (HUMAN IMMUNOGLOBULIN G)
    CSL Behring AG
    HIZENTRA is indicated for the treatment of primary immunodeficiency in patients aged 2 and older, including various humoral immune defects. It is also used as maintenance therapy for adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability.

  • hyqvia

    (Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase)
    Takeda Pharmaceuticals America, Inc.
    HYQVIA is indicated for treating primary immunodeficiency (PI) in adults and children over two, including conditions like common variable immunodeficiency and Wiskott-Aldrich syndrome. It is also used as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to prevent relapse of neuromuscular symptoms.